The Biomedical Alliance in Europe organises regular teleconferences in different formations and organises multiple face-to-face meetings.

There are two annual meetings for all members; the Spring Meeting and at the end of the year the General Assembly. These meetings provide an opportunity to discuss activities and relevant policy developments, take important internal decisions and to network.

In addition, the Committee, Taskforces and Working Group organise regular meetings depending on the activities and availability of their members. During these meetings, members exchange information and jointly work on common projects.

The BioMed Alliance also contributes to the organisation of ad-hoq events on topics that are relevant to its members.

Upcoming events

The next General Assembly will take place on 26 November 2020, depending on COVID-19 restrictions it will either take place online or in the BioMed Alliance’s office in Brussels. The programme will include discussions on policy topics and internal affairs and the agenda will be published in due time.


Past events

spring meeting 2020

Due to the COVID-19 Pandemic, the BioMed Alliance leadership decided to host the 2020 version of the Spring Meeting online. During the virtual meeting discussed the latest developments at EU level, the activities of the BioMed Alliance and its different taskforces and decided on internal affairs. There were two break-out sessions as well, on the future of medical societies and the future of health research.

activities 1

On 31 January, the BioMed Alliance organised a joint event with the Federation of European Academies of Medicine (FEAM) in the European Parliament. The event was attended by around 80 participants and was hosted by MEP Cristian Bușoi (EPP), MEP Maria da Graça Carvalho (EPP) and MEP Petra De Sutter (Greens/EFA). There were speakers from the European Commission, the European Patients Forum, Academia and EFPIA and our President Wilfried Ellmeier chaired the panel discussion.

With the increasing disease burden and challenges faced by European healthcare systems, health research is more important than ever. This was highlighted by the speakers and they also reflected on the barriers that should be overcome in the health research field. Discussions showed that there are interesting developments in biomedical research at policy level. In the coming years, policy makers will work e.g. on the implementation of Horizon Europe, several partnerships in health and the development of the European Health Data Space. The key word of the day was partnerships, it is vital that the European Institutions, Member States, academia, patients, industry and other stakeholders work together to ensure innovative ideas get the right support and can be translated into concrete solutions for European patients.

The report of the workshop is available here

activities 2

During the Berlin Science Week 2019, the Berlin Institute of Health organised in partnership with “Der Tagesspiegel” (Germany’s leading capital newspaper) the 4th Future Medicine Science Match on 7 Nov attracting up to 800 participants. Within this framework, the Biomedical Alliance in Europe in partnership with the Berlin Institute of Health organised an afternoon session to promote the value of health research and explore ways to bridge the gaps between basic and translational approaches. The session was well attended and included a panel of leading scientists and European and National Policy Makers.

activities 3

The BioMed Alliance and the European Association of Urology (EAU) organised a workshop on Horizon Europe and the EU research funding landscape in Europe. The workshop entitled ‘Navigating EU health research funding. Looking ahead to Horizon Europe 2021-2027’ took place on 19 November 2019.

The workshop took an in-depth look at funding opportunities within the new framework programme, particularly for biomedical and health research. The event was divided into four parts: an introduction, an overview of EU funding opportunities for health research, a panel discussion on strategic approaches and an exchange on tips for success.

On 14 May, the BioMed Alliance organised its 2019 Spring Meeting bringing together around 60 participants for discussions on the European Elections, Plan S and BioMed Alliance activities.

spring meeting photo

The Biomed Alliance opened its doors to representatives of member organisations and external speakers. The day began with a presentation by Richard Steel from Interel on the stakes in the European Elections. Afterwards, speakers from Wellcome Trust, the European Commission and the European Heart Journal exchanged expertise and positions on Plan S and its consequences for health research and medical societies. The afternoon session was dedicated to ongoing BioMed Alliance activities and work in the Committee and Taskforces.

For more information, see the agenda and the minutes.

The 2019 General Assembly took place on 20 November in our offices in Brussels. We were happy to see so many of our members there to exchange views on activities, policy developments and potential directions for the future.

We started the day by taking a closer look at our past activities and our role in shaping EU policies. This included an overview by Prof. Karin Sipido of the achievements of the Scientific Panel for Health (which was established based on a BioMed Alliance proposal). We also discussed the results of a survey which collected input from members about BioMed Alliance activities and explored potential ways forward with all participants.

As a follow-up to the panel discussion on Plan S during the spring meeting, Valentina Tursini, Scientific Publications Director (ESC) presented the latest developments regarding Plan S. Since the Spring Meeting there have been several new developments, e.g. the application date of Plan S was postponed to 2021 and a new guidance for medical societies was published.

The afternoon session was dedicated to discussing the activities of taskforces, committees and to discussing finances and governance.

Upcoming changes in governance were also discussed. Prof. Wilfried Ellmeier starts his presidential mandate in January 2020. He is supported by prof. Gunhild Waldemar in her capacity as President-Elect and by prof. Axel Pries who will act as Past-President. The term in office of Past President Colm O’Morain comes to an end in 2019. Over the past years, he has worked hard to promote the BioMed Alliance and advance the interests of its members. Tom Hemming Karlsen from EASL was elected to take over his empty seat.

GA 2019

BioMed Alliance General Assembly 2018

The BioMed Alliance’s General Assembly was held on 21 November in Brussels. It was a successful meeting attended by 35 delegates representing 22 member societies and by a wide-range of stakeholders from European Parliament, UEMS, EFPIA and EPF. The programme covered topics such as:

  • elections and revision of the BioMed Alliance’s mission and internal rules
  • update on the BioMed Alliance’s activities
  • the role of the BioMed Alliance in the EU health arena
  • a session dedicated to the Horizon Europe to the Steering Board for Health.

The BioMed Alliance’s mission and internal rules have been adopted by the General Assembly. The new mission will allow the BioMed Alliance to act as a unified voice for its members and to present their views in a cohesive and comprehensible form to policymakers, and the public at large. Following the new mission, the BioMed Alliance’s principal goals and objectives are to promote the best interests and values of researchers and of healthcare professionals, organised in non-for-profit scientific medical associations and organisations across all medical disciplines in Europe, in those general areas where common interest is identified.

BioMed Alliance General Assembly Agenda

BioMed GA 2018 Minutes

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.